Research Topic · Peer-Reviewed

Vasodilators

Hypertension is a medical condition that is characterized by high blood pressure. It is a chronic disease that affects millions of people worldwide and can lead to serious health complications. Cardiology, on the other hand, is a branch of medicine that deals with the diagnosis and treatment of heart diseases. One …

Curated from this journal's research 📚 3 peer-reviewed articles cited Cited 5× across the literature 🔖 ISSN 2329-9487 🗓 Reviewed June 2026

Overview

Hypertension is a medical condition that is characterized by high blood pressure. It is a chronic disease that affects millions of people worldwide and can lead to serious health complications. Cardiology, on the other hand, is a branch of medicine that deals with the diagnosis and treatment of heart diseases. One of the most common treatments for hypertension and other cardiovascular diseases is the use of vasodilators. Vasodilators are a group of drugs that act on the blood vessels to widen them, thus lowering blood pressure and improving blood flow to the heart. Vasodilators work by relaxing the smooth muscles in the walls of blood vessels, causing them to widen. This reduces the resistance to blood flow, which in turn lowers blood pressure. There are several types of vasodilators, including nitrates, calcium channel blockers, and ACE inhibitors. Nitrates, such as nitroglycerin, are commonly used to treat angina or chest pain caused by coronary artery disease. They work by dilating the coronary arteries, allowing more blood to flow to the heart muscle. Calcium channel blockers, such as verapamil and diltiazem, work by blocking the entry of calcium into smooth muscle cells, reducing the force of contraction and widening blood vessels. ACE inhibitors, such as lisinopril and enalapril, work by blocking the production of angiotensin II, a hormone that constricts blood vessels. This leads to vasodilation and lowers blood pressure. In summary, vasodilators are an important treatment option for hypertension and other cardiovascular diseases. They act by widening blood vessels, reducing resistance to blood flow, and improving blood flow to the heart. Proper use and management of these drugs can significantly improve the quality of life and overall health of patients.

Research published in this journal

3 peer-reviewed articles, ranked by relevance. Each links to its DOI.

How this research is being cited

The 3 articles above have been cited 5 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Vasodilators, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in Hypertension and Cardiology (ISSN 2329-9487).

Journal editorial board
Hatori Nobuo · Japan Gregor Leibundgut · Switzerland Yuejin Li · United States

This page summarises published research for orientation; it is not medical or professional advice.